Global Information
ȸ»ç¼Ò°³ | ¹®ÀÇ | À§½Ã¸®½ºÆ®

À¯·´ ±¹°¡(ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹)ÀÇ ºÐÀÚ Áø´Ü ½ÃÀå

Europe Nucleic Acid Testing/NAT Market for 100 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

¸®¼­Ä¡»ç Venture Planning Group
¹ßÇàÀÏ »óǰ ÄÚµå 233420
ÆäÀÌÁö Á¤º¸ ¿µ¹®
°¡°Ý
US $ 12,800 £Ü 15,392,000 DataPack
US $ 19,700 £Ü 23,689,000 PDF by E-mail (Local License)
US $ 28,500 £Ü 34,271,000 PDF by E-mail (Global License)


À¯·´ ±¹°¡(ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹)ÀÇ ºÐÀÚ Áø´Ü ½ÃÀå Europe Nucleic Acid Testing/NAT Market for 100 Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing
¹ßÇàÀÏ : ÆäÀÌÁö Á¤º¸ : ¿µ¹®

À¯·´ ÁÖ¿ä 5°³±¹(ÇÁ¶û½º, µ¶ÀÏ, ÀÌÅ»¸®¾Æ, ½ºÆäÀÎ, ¿µ±¹) ºÐÀÚ Áø´Ü(Molecular Diagnostics) ½ÃÀåÀÇ Ãֽе¿Çâ°ú ÇâÈÄ Àü¸Á¿¡ ´ëÇØ ºÐ¼®Çϰí, °Ë»ç ±â¼ú ¿¬±¸°³¹ß Ãֽе¿Çâ, °¢±¹ ½ÃÀå ±âº» ±¸Á¶¿Í µ¿Çâ, ÇâÈÄ 5³â°£ ½ÃÀå µ¿Çâ ¿¹Ãø, ½ÃÀå È®ÀåÀ» À§ÇÑ Àü·«°ú °úÁ¦, ÁÖ¿ä ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

1. ¼­·Ð

2. ¼¼°è ½ÃÀå°ú ±â¼ú °³¿ä

  • DNA ½ÃÄö½Ì
    • ¼­·Ð
    • ½ÃÄö½Ì ¹æ¹ý
    • ¿ÀÅä¶óµð¿À±×·¡ÇÇ
    • Àΰ£°Ô³ð ÇÁ·ÎÁ§Æ®
    • ½ÃÄö½Ì ÀÚµ¿È­
    • À̹ÌÁö ½ºÄ³³Ê
    • Çü±¤ °ËÃâ
    • À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµ
    • À¯ÀüÀÚ ¹ßÇö
    • À¯ÀüÀÚ ´ÙÇü
    • ´Ü¹éÁú »óÈ£ÀÛ¿ë ³×Æ®¿öÅ©
  • DNA ¹× RNA ÇÁ·Îºê ±â¼ú
    • ±âº»Àû ¿øÄ¢
    • ÇÁ·Îºê ºÐ¸®
    • DNA ÇÁ·Îºê °Ë»ç
    • °Ë»ç Æ÷¸Ë
    • Ç¥Áö ±â¼ú
    • ÁõÆø ¹æ¹ý
  • °ËÃâ ±â¼ú
    • ¹æ»ç¼±¿¡ ÀÇÇÑ ¹æ¹ý
    • Non-Isotopic ¹æ¹ý
  • ÀåÄ¡ ¸®ºä
    • Abbott LCx
    • Beckman Coulter/Biomek FK
    • Becton Dickinson SDA
    • Bio-Rad GeneScope
    • Gen-Probe Tigris
    • Roche Cobas Amplicor
    • Tecan LS Series
  • ¹ÙÀÌ¿ÀĨ : °Ô³ë¼¾¼­, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Labs-on-the-chip
    • ¾×ü ¼ö¼Û ¹× È¥ÇÕ
    • ºÐ¸®
    • ¹ÝÀÀ
    • ŽÁö
  • ¾à¹°À¯Àüü(Pharmacogenomics)
  • ÁÖ¿ä ÀÀ¿ë ºÐ¾ß
    • ¹Ì»ý¹°ÇÐ/°¨¿°Áõ
    • ¾Ï°Ë»ç
    • À¯Àü¼º Áúȯ
    • ¹ýÀÇÇÐÀû °Ë»ç
    • Ä£ÀÚ °¨Á¤/HLAÇü °áÁ¤
    • ±âŸ ÀÀ¿ë ºÐ¾ß
  • °æÀï ¹× º¸¿Ï ±â¼ú
    • ´ÜÀÏŬ·ÐÇ×ü/¸é¿ªºÐ¼®
    • RNA ÇÁ·Îºê
    • 2Â÷ Àü±â¿µµ¿
    • À¯¼¼Æ÷ºÐ¼®±â(Flow Cytometry)

3. ÇÁ¶û½º ½ÃÀå

  • °³¿ä
  • »ç¾÷ ȯ°æ
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå±Ô¸ð, ¼ºÀå·ü, ÁÖ¿ä °ø±Þ¾÷ü ¸ÅÃâ¾× ¹× ½ÃÀå Á¡À¯À²

4. µ¶ÀÏ ½ÃÀå

  • °³¿ä
  • »ç¾÷ ȯ°æ
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå±Ô¸ð, ¼ºÀå·ü, ÁÖ¿ä °ø±Þ¾÷ü ¸ÅÃâ¾× ¹× ½ÃÀå Á¡À¯À²

5. ÀÌÅ»¸®¾Æ ½ÃÀå

  • °³¿ä
  • »ç¾÷ ȯ°æ
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå±Ô¸ð, ¼ºÀå·ü, ÁÖ¿ä °ø±Þ¾÷ü ¸ÅÃâ¾× ¹× ½ÃÀå Á¡À¯À²

6. ½ºÆäÀÎ ½ÃÀå

  • °³¿ä
  • »ç¾÷ ȯ°æ
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå±Ô¸ð, ¼ºÀå·ü, ÁÖ¿ä °ø±Þ¾÷ü ¸ÅÃâ¾× ¹× ½ÃÀå Á¡À¯À²

7. ¿µ±¹ ½ÃÀå

  • °³¿ä
  • »ç¾÷ ȯ°æ
  • ½ÃÀå ±¸Á¶
  • ½ÃÀå±Ô¸ð, ¼ºÀå·ü, ÁÖ¿ä °ø±Þ¾÷ü ¸ÅÃâ¾× ¹× ½ÃÀå Á¡À¯À²

8. ÁÖ¿ä Á¦Ç° °³¹ß ±âȸ

  • ±â±â
  • ½Ã¾à ŰƮ ¹× °Ë»ç ½Ã½ºÅÛ/ÆÐ³Î
  • ÄÄÇ»ÅÍ, ¼ÒÇÁÆ®¿þ¾î, ¿ÀÅä¸ÞÀ̼Ç
  • º¸Á¶ Á¦Ç°

9. ºÐ»êÇü °Ë»ç Á¦Ç° ¼³°è ±âÁØ

10. ´ëüÀû ½ÃÀå ÁøÃâ Àü·«

  • ³»ºÎ °³¹ß
  • ÇÕÀÛÅõÀÚ ÇùÁ¤
  • ´ëÇаúÀÇ °è¾à
  • ºÐ»êÇü °Ë»ç ½ÃÀå À¯Åë Àü·«
    • ¸¶ÄÉÆÃ ¹æ¹ý
    • Á¦Ç° º¹À⼺
    • °í°´ ¼±È£
    • ±âÁ¸ °ø±Þ¾÷ü
    • ½Å±Ô ÁøÃâ °ø±Þ¾÷ü
    • ÁÖ¿ä Á¾·ùÀÇ À¯Åë¾÷ü
    • ½ÃÀå ¼¼ºÐÈ­

11. ÀáÀçÀû ½ÃÀå ÁøÃâ À庮°ú À§Çè

  • ½ÃÀå ¼º¼÷È­
  • ºñ¿ë ¾ïÁ¦
  • °æÀï
  • ±â¼ú ÇѰè
  • ƯÇã º¸È£
  • ±ÔÁ¦¿¡ ÀÇÇÑ ¾ïÁ¦
  • ºÐ»êÇü °Ë»ç ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦

12. °æÀï»ç °³¿ä

  • Abbott
  • Affymetrix
  • Agilent
  • Applied Gene Technologies
  • Arca
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio
  • Gen-Probe
  • Hologic
  • Illumina
  • Innogenetics/Solvay
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Novartis
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

13. ºÎ·Ï

  • ºÎ·Ï I : ÁÖ¿ä ´ëÇÐ ¹× ¿¬±¸±â°ü
  • ºÎ·Ï II : ¿ë¾îÁý
  • ºÎ·Ï III : ÇöÀç ȯÀ²

µµÇ¥

KSM 12.03.22

¡Ø ÀÌ ÆäÀÌÁö¿¡ °ÔÀçµÇ¾î ÀÖ´Â ³»¿ëÀº ÃÖ½ÅÆÇ°ú ¾à°£ Â÷À̰¡ ÀÖÀ» ¼ö ÀÖÀ¸¹Ç·Î ¿µ¹®¸ñÂ÷¸¦ ÇÔ²² ÂüÁ¶ÇÏ¿© Áֽñ⠹ٶø´Ï´Ù. ±âŸ ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇ ¹Ù¶ø´Ï´Ù.

This new 1,273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estimates shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

The $4.5 billion molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of and cost-effective automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostics companies during the next five years.  

Table of Contents

I.       Introduction

II.      Worldwide Technology and Market Overview

          A.  DNA Sequencing
             
          B.  DNA and RNA Probes Technology
             
          C.  Detection technologies
             
          D.  Instrumentation Review
                        
          E.  Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

          F.  Pharmacogenomics

          G.  Major Applications

III.     France

IV.     Germany

V.      Italy

VI.     Spain

VII.    U.K.

VIII.   Major Product Development Opportunities

IX.     Design Criteria for Decentralized Testing Products

X.      Alternative Market Penetration Strategies

XI.     Potential Market Entry Barriers and Risks

XII.    Competitive Assessments

XIII.   Appendix
                                                                                            
Contains 1,273 pages and 139 tables

Table of Contents

I. Introduction

II. Worldwide Technology and Market Overview

  • A. DNA Sequencing
  • B. DNA and RNA Probes Technology
  • C. Detection Technologies
  • D. Instrumentation Review
  • E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
  • F. Pharmacogenomics
  • G. Major Applications

III. France

IV. Germany

V. Italy

VI. Spain

VII. U.K.

VIII. Major Product Development Opportunities

IX. Design Criteria for Decentralized Testing Products

X. Alternative Market Penetration Strategies

XI. Potential Market Entry Barriers and Risks

XII. Competitive Assessments

XIII. Appendix

Back to Top
ÀüÈ­ ¹®ÀÇ
F A Q